Healthcare - Biotechnology - NASDAQ - US
$ 1.105
-13.7 %
$ 38.6 M
Market Cap
-0.35
P/E
Price Target
Average
1761.67%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
39.75%
Net Income
Estimate
9.37%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
RAPT Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for RAPT of $20.6 , with forecasts ranging from a low of $2 to a high of $55 .
RAPT Lowest Price Target
Wall Street Target
2 USD
81.00%
RAPT Average Price Target
Wall Street Target
20.6 USD
1761.67%
RAPT Highest Price Target
Wall Street Target
55 USD
4877.38%
REVENUE FORECAST
Revenue Forecast Chart RAPT
EBIT FORECAST
EBIT Forecast Chart RAPT
NET INCOME FORECAST
Net Income Chart RAPT